Soluble cytokine receptors: their role in immunoregulation - PubMed (original) (raw)
Review
Soluble cytokine receptors: their role in immunoregulation
R Fernandez-Botran. FASEB J. 1991 Aug.
Abstract
A number of cytokine receptors exist in soluble form in the biological fluids of both animals and humans, a phenomenon that might have immunoregulatory implications in vivo. Although these soluble receptors specifically inhibit binding and activity of their respective cytokines in vitro, their actual function in vivo as cytokine inhibitors or as carrier proteins is unclear. Abnormalities in the production of these substances might contribute to the pathophysiology of immune and neoplastic diseases. Besides their role in regulating cytokine activity in vivo, soluble cytokine receptors hold significant potential for therapeutic use as very specific anticytokine agents and as indicators in diagnosis and assessment of immune parameters, prognosis, disease progression, response to treatment, etc., in a variety of autoimmune and malignant diseases.
Similar articles
- Immunoregulation in clinical diseases: an overview.
Ricci M. Ricci M. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S3-12. doi: 10.1016/0090-1229(89)90109-8. Clin Immunol Immunopathol. 1989. PMID: 2642769 Review. - The biological role of naturally-occurring cytokine inhibitors.
Arend WP, Malyak M, Bigler CF, Smith MF Jr, Janson RW. Arend WP, et al. Br J Rheumatol. 1991;30 Suppl 2:49-52. Br J Rheumatol. 1991. PMID: 1847086 Review. - Soluble cytokine receptors: basic immunology and clinical applications.
Fernandez-Botran R. Fernandez-Botran R. Crit Rev Clin Lab Sci. 1999 Jun;36(3):165-224. doi: 10.1080/10408369991239196. Crit Rev Clin Lab Sci. 1999. PMID: 10407682 Review. - Anti-inflammatory cytokines.
Opal SM, DePalo VA. Opal SM, et al. Chest. 2000 Apr;117(4):1162-72. doi: 10.1378/chest.117.4.1162. Chest. 2000. PMID: 10767254 Review. - Cytokines and anti-cytokines as therapeutics--an update.
Tayal V, Kalra BS. Tayal V, et al. Eur J Pharmacol. 2008 Jan 28;579(1-3):1-12. doi: 10.1016/j.ejphar.2007.10.049. Epub 2007 Oct 25. Eur J Pharmacol. 2008. PMID: 18021769 Review.
Cited by
- Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease.
Cortez-Cooper M, Meaders E, Stallings J, Haddow S, Kraj B, Sloan G, McCully KK, Cannon JG. Cortez-Cooper M, et al. Vasc Med. 2013 Oct;18(5):282-9. doi: 10.1177/1358863X13508336. Vasc Med. 2013. PMID: 24165468 Free PMC article. - Secretory component (polymeric immunoglobulin receptor) as an intrinsic inhibitor of biological functions of interferon gamma in keratinocytes.
Nihei Y, Maruyama K, Zhang JZ, Kobayashi K, Kaneko F. Nihei Y, et al. Arch Dermatol Res. 1995;287(6):546-52. doi: 10.1007/BF00374074. Arch Dermatol Res. 1995. PMID: 7487140 - Tolerance to appetite suppression induced by peptidoglycan.
Biberstine KJ, Darr DS, Rosenthal RS. Biberstine KJ, et al. Infect Immun. 1996 Sep;64(9):3641-5. doi: 10.1128/iai.64.9.3641-3645.1996. Infect Immun. 1996. PMID: 8751911 Free PMC article. - UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytes.
Dummer R, Meyer JC, Ballmer-Weber BK, Muletta S, Panizzon R, Burg G. Dummer R, et al. Arch Dermatol Res. 1993;285(4):230-2. doi: 10.1007/BF00372015. Arch Dermatol Res. 1993. PMID: 8102046 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical